Remove tag
article thumbnail

Coherus plans Humira biosimilar sale at 85% discount

Pharmaceutical Technology

Yusimry is priced at $995 per carton of two autoinjectors compared to Humira’s price tag of $6,922 for the same quantity.

Sales 130
article thumbnail

Enhertu gets breakthrough tag in HER2-low breast cancer

pharmaphorum

Analysts at Credit Suisse have said that expanding Enhertu’s use into HER2-low cancers could expand its sales by $3 billion, and unlock the multibillion-dollar predictions that prompted AZ to pay $1.4 The post Enhertu gets breakthrough tag in HER2-low breast cancer appeared first on.

Sales 58
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gilead tags Merck for first-line triple negative breast cancer trial

pharmaphorum

Trodelvy is also approved to treat metastatic urothelial cancer in the US, and Gilead has just reported third-quarter sales of $101 million for the drug, which were actually a little lower than analyst expectations. billion in sales during the three-month period – way ahead of projections – with turnover expected to reach up to $4.8

Trials 52
article thumbnail

FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag

pharmaphorum

Analysts at GlobalData think that Biogen will have challenges rolling out Aduhelm in the US, but are still predicting sales of $5.6 The post FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag appeared first on. billion in 2027.

Drugs 98
article thumbnail

Global (68M) cardiomyopathies market projected to grow to $9.63bn by 2031

Pharmaceutical Technology

In an expanded version of the sales forecast from GlobalData’s June 2022 publication, Cardiomyopathies: Global Drug Forecast and Market Analysis , the global cardiomyopathies market is expected to grow from $3.07bn last year to $9.63bn in 2031. of sales in 2021 and 2031 respectively. of global cardiomyopathies sales in 2021 and 31.2%

Marketing 130
article thumbnail

Roche nabs breakthrough tag for TIGIT cancer immunotherapy

pharmaphorum

First-line immunotherapy for NSCLC is dominated by Merck & Co’s PD-1 inhibitor Keytruda (pembrolizumab), transforming the prospects of some patients and propelling the drug to multibillion-dollar sales. The post Roche nabs breakthrough tag for TIGIT cancer immunotherapy appeared first on.

article thumbnail

What are McDonald’s Boo Buckets? + Why Campbell’s Acquired Rao’s Sauce – Xtalks Food Podcast Ep. 133

XTalks

In fact, Rao’s accounted for nearly 70 percent of Sovos Brands’ 2022 sales, or $837 million. Despite the premium price tag, the brand has gained a cult following thanks to its inclusion of high quality ingredients and successful word-of-mouth marketing.